Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang

Post date April 25, 2022 — 11:42 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

The securities sector rose 1.63%, Caida Securities rose 10.03% to top the list – yqqlm

May 20, 2022 — 16:50

New energy vehicles show super traditional product power in medium and long-term demand. Orient Securities: Materials sector will usher in systematic opportunities in the second half of the year.

May 17, 2022 — 17:16

Fujifilm fell 5.92%, IPO raised 330 million yuan and net profit fell for 2 consecutive years – yqqlm

May 17, 2022 — 17:11

37 listed securities companies plan to distribute 57.746 billion yuan in dividends, an increase of 21% year-on-year. The dividend rate of these two securities companies exceeds 5%

May 17, 2022 — 14:34

37 listed securities companies plan to distribute 57.746 billion yuan in dividends, a year-on-year increase of 21%. The dividend rate of these two securities companies exceeds 5%! -Funds Financial Sector

May 17, 2022 — 12:50

Heavy! Shanghai has achieved social zero; A-shares fluctuated, and the Hang Seng Index rose by more than 2%; many high-end stocks crashed and fell by the limit, and even individual stocks fell by more than 70%… What happened? -Stock Channel-Hexun.com

May 17, 2022 — 12:46

After Russia-Ukraine conflict cuts off a quarter of supply, India announces ban on exports! Who is harvesting young wheat crops at high prices? Agricultural stocks usher in a highlight moment (with shares) Stock Channel Hexun.com

May 16, 2022 — 15:52

With the introduction of stricter regulatory policies for energy-intensive industries in many places, how can the cement industry outperform the "dual-carbon" track?

May 16, 2022 — 10:15

It's time for investment and advisory institutions to join hands with Big V! Two cooperation models promote the transformation of stock portfolios, and existing big V holders have begun to work-Fund Channel-Hexun Network

May 16, 2022 — 10:12

Home » News » Orient Securities maintains Bairen Medical's buy rating: the enrollment of ophthalmic biological patches has been completed, and the research and development has gradually entered the harvest period. The target price is 207.59 yuan per Jingwang